Jennifer Riley insider trades
Open-market stock purchases and sales by Jennifer Riley, Chief Strategy Officer at Avalo Therapeutics, Inc, from SEC Form 4 filings since Jan 1, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 11, 2026 | AVTX Avalo Therapeutics, Inc | Sold | $52K |
| Jun 10, 2026 | AVTX Avalo Therapeutics, Inc | Sold (not open market) | $7.7K |
| May 21, 2026 | AVTX Avalo Therapeutics, Inc | Bought (not open market) | — |
| Feb 26, 2026 | AVTX Avalo Therapeutics, Inc | Bought (not open market) | — |
| Dec 10, 2025 | AVTX Avalo Therapeutics, Inc | Sold (not open market) | $2.6K |
Companies traded
- AVTX Avalo Therapeutics, Inc: 1 sale, last Aug 11, 2026